Lixte Biotechnology Holdings's total assets for Q2 2025 were $1.19M, a decrease of -21.51% from the previous quarter. LIXT total liabilities were $537.12K for the fiscal quarter, a 51.26% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.